Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The GUMMMy Bear Squad touting Gum Tech (NASDAQ: GUMM) -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (128)	2/3/2000 11:20:00 PM
From: Mad2	Read Replies (1) \| Respond to of 207

Kevin, apparantly GUMM is stepping up advertizing (TV commercials), spending that is. Next few months will be quite interesting. Theres a lot of expectation built into this price (giving 50 mil to the gum operations leaves 210 mil for GUMM's 60% interest in Gel Tech, valuing Gel Tech at 350 mil.....a bit steep) Mad2

To: Kevin Podsiadlik who wrote (128)	2/4/2000 11:14:00 PM
From: Hank	Read Replies (2) \| Respond to of 207

Hey, I've said all along that it's possible to see a product like Zicam sell well it's first cold season out. After all, we Americans are addicted to anything new and cutting edge. Of course, once people try Zicam and find out that it 1) doesn't work as advertised, 2) is relatively unpleasent to use, 3) is slow to act and 4) is relatively expensive relative to any one of dozens of fast acting remedies, they will stop buying. Maybe the people that shop at Albertson's already fell for the zinc lozenge scam and weren't willing to get suckered in twice.